Similar articles

• Cytochrome P450 dependent monooxygenases in nasal epithelial membranes: effect of phenobarbital and benzo(A)pyrene.

  Hadley WM, Dahl AR, Benson JM, Hahn FF, McClellan RO. Hadley WM, et al. Proc West Pharmacol Soc. 1982;25:197-9. Proc West Pharmacol Soc. 1982. PMID: 6289337 No abstract available.
• Hamster hepatic nuclear mixed-function amine oxidase: location and specific activity.

  Patton SE, Rosen GM, Rauckman EJ, Graham DG, Small B, Ziegler DM. Patton SE, et al. Mol Pharmacol. 1980 Jul;18(1):151-6. Mol Pharmacol. 1980. PMID: 7412759 No abstract available.
• Drug monooxygenase activity in the harderian gland.

  Krieg T, Goerz G, Lissner R, Bolsen K, Ullrich V. Krieg T, et al. Biochem Pharmacol. 1978 Feb 15;27(4):575-7. doi: 10.1016/0006-2952(78)90397-0. Biochem Pharmacol. 1978. PMID: 629818 No abstract available.
• Developmental aspects of the hepatic cytochrome P450 monooxygenase system.

  Neims AH, Warner M, Loughnan PM, Aranda JV. Neims AH, et al. Annu Rev Pharmacol Toxicol. 1976;16:427-45. doi: 10.1146/annurev.pa.16.040176.002235. Annu Rev Pharmacol Toxicol. 1976. PMID: 820239 Review. No abstract available.
• Metabolic basis for the pulmonary Clara cell as a target for pulmonary carcinogenesis.

  Boyd MR, Reznik-Schüller HM. Boyd MR, et al. Toxicol Pathol. 1984;12(1):56-61. doi: 10.1177/019262338401200109. Toxicol Pathol. 1984. PMID: 6387866 Review.